Dr. Nair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030
Education & Training
- Medical College TrivandrumClass of 2009
Certifications & Licensure
- FL State Medical License 2021 - Present
- GA State Medical License 2022 - 2026
- TX State Medical License 2018 - 2026
- AL State Medical License 2022 - 2025
- AZ State Medical License 2022 - 2025
- LA State Medical License 2022 - 2025
- MS State Medical License 2022 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity Start of enrollment: 2024 Feb 08
Roles: Contact, Principal Investigator
- PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy Start of enrollment: 2021 May 10
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian
Nature Communications. 2024-10-07 - Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With ...Gohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, Elaine E Cha, Alison K Yoder
International Journal of Radiation Oncology, Biology, Physics. 2024-09-19 - 2 citationsBrentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymp...Alex F Herrera, Jasmine Zain, Kerry J Savage, Tatyana Feldman, Jonathan E Brammer
The Lancet. Haematology. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: